Introduction to Advanced Imaging in CTEPH

Chronic thromboembolic pulmonary hypertension (CTEPH) is a severe, potentially curable form of pulmonary hypertension. Accurate MRI for CTEPH diagnosis is becoming increasingly important as clinicians seek radiation-free alternatives to traditional scans. A recent systematic review published in the Journal of Medical Imaging and Radiation Oncology evaluates how magnetic resonance imaging (MRI) performs in identifying thromboembolic material and perfusion defects. Researchers analyzed nine studies involving 563 participants to synthesize evidence on various MRI techniques.

Key Findings on MRI for CTEPH Diagnosis

The systematic review highlighted that MRI perfusion imaging is remarkably effective. Across the analyzed studies, MRI perfusion demonstrated a median sensitivity of 97% and a median specificity of 92.5%. Additionally, contrast-enhanced MR angiography (ce-MRA) showed high specificity at 98.1%, making it a robust tool for identifying vascular obstructions. While non-contrast MRA had lower accuracy when used alone, it provided significant value for assessing proximal vessels when combined with contrast-enhanced techniques. Consequently, the combination of these modalities offers a comprehensive view of both vascular morphology and cardiopulmonary function.

Advantages and Limitations in Clinical Practice

The primary advantage of using MRI is the lack of ionizing radiation. This feature is particularly beneficial for patients requiring longitudinal follow-up or those sensitive to radiation. However, the review also identified some methodological limitations. Most studies used non-consecutive patient selection and exhibited significant heterogeneity in MRI protocols. Therefore, while the diagnostic performance is encouraging, specialists still need larger, standardized prospective studies to fully integrate MRI into standard diagnostic pathways. In India, where access to specialized PH centers is growing, these findings support the potential for MRI to serve as a versatile diagnostic alternative.

Frequently Asked Questions

How sensitive is MRI perfusion for detecting CTEPH?

MRI perfusion is highly sensitive, with a median sensitivity of 97% according to the latest systematic review. This makes it an excellent tool for identifying perfusion defects in the lungs without using radiation.

Does non-contrast MRA have a role in CTEPH diagnosis?

While non-contrast MRA has lower standalone accuracy (45% sensitivity), it is useful for assessing proximal vessels. It improves significantly when used in conjunction with contrast-enhanced MR angiography (ce-MRA).

Can MRI replace CTPA or V/Q scans for CTEPH?

MRI shows encouraging diagnostic performance that is comparable to standard tests. However, due to study heterogeneity, current guidelines often still prioritize V/Q scintigraphy or CTPA. MRI is currently a valuable adjunct, especially when radiation avoidance is a priority.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Tai JYY et al. Diagnostic Performance of Magnetic Resonance Imaging in Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review. J Med Imaging Radiat Oncol. 2026 Apr 12. doi: 10.1111/1754-9485.70101. PMID: 41968355.

2. Humbert M, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618-3731.

3. Rajagopalan S, et al. Magnetic resonance imaging in pulmonary hypertension: An update. Indian J Radiol Imaging. 2021;31(1):145-154.